New online classes aim to ease MS muscle tightness
NCT ID NCT03166930
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two online programs designed to help people with multiple sclerosis manage spasticity (muscle tightness) in their legs. Participants attended two video classes that included education and stretching exercises. The goal was to see if these programs could reduce the impact and severity of spasticity. The study involved 232 people with MS who could walk with or without assistance.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Spasticity Take Control and Stretching for People with MS: An Illustrated Manual (behavioral interventions)
- What this could lead to
- If successful, this could provide simple, accessible online tools to help people with MS reduce leg spasticity and improve daily life.
- What could go wrong
- This is a completed study comparing two behavioral programs, not a new drug or cure. Results may show only modest benefits, and the programs may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
232 people
The number who actually took part.
- Started
-
Jan 2018
- Finished
-
Jan 2022
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A diagnosis of definite MS by 2010 updated McDonald Criteria * Age 18 or older * Able to walk 25 feet with any assistive devices (Patient Determined Disease Steps 0-6) * Fluent in written and spoken English, as materials are not validated in languages other than English. * Presence of self-reported lower extremity spasticity that is interfering with daily activities or sleep, using the this definition: Have spasticity in your legs with unusual tightening of muscles that feels like leg stiffness, jumping of the legs, a repetitive bouncing of the foot, muscle cramping in the legs, or the legs going out tight and straight or drawing up. * All women that meet the above criteria * Only Veteran men that meet the above criteria Exclusion Criteria: * Any uncontrolled medical or mental condition that would limit participation or completion of the study * Any self-reported musculoskeletal or neurological condition other than MS that is known to cause spasticity
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Portland Health Care System, Portland, OR
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise rebuild muscle and balance in MS?
- Can diet ease the crushing fatigue of multiple sclerosis?
- One-Time CAR-T infusion tested against progressive MS
- Can PET scans reveal hidden brain inflammation in MS?
- Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
- Migraines and tension headaches may be hidden companions to multiple sclerosis